The findings are the latest setback for weight loss medicines that target a specific cannabinoid receptor and are meant to ...

Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...

The results could pave the way for Datroway to supplant chemotherapy in certain triple-negative tumors, adding to existing ...

Implementing artificial intelligence requires significant human labor and technical expertise, threatening to create a ...

In a Phase 2 trial, a drug at the center of the $4.9 billion deal matched the type of weight loss trajectory seen in testing ...

The biotech is starting up with partial rights to a drug that’s approved in multiple Asian countries and its executives see ...

The Italian drugmaker will pay as much as $115 million in upfront and near-term payments in a deal that gives it rights to a ...

George Tidmarsh criticized Aurinia’s lupus drug in a later-retracted social media post. Elsewhere, the FDA approved a new ...

The decision to clear another mifepristone generic sparked political backlash. Elsewhere, Medicare delayed a decision on whether to subject “combination” drugs to pricing negotiations, and a cancer ...

The funding lapse triggered by the U.S. government shutdown is the latest test for an agency that’s already dealt with ...

The company is working on T cell engagers and other multifunctional antibodies, led by a prospect it believes might be ...

Dublin-based Aerska launched on Wednesday with $21 million in seed funding and a technology designed to shuttle RNA ...